K. V. van Garderen

EASE: Clinical Implementation of Automated Tumor Segmentation and Volume Quantification for Adult Low-Grade Glioma

S. Klein, M. van Straten, M. Smits, 2021, Frontiers in Medicine.

Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI

D. Poot, M. Smits, J. Hernandez-Tamames, 2022, Scientific reports.

Effect of Applying Leakage Correction on rCBV Measurement Derived From DSC-MRI in Enhancing and Nonenhancing Glioma

Paula L. Croal, M. Chappell, E. Warnert, 2021, Frontiers in Oncology.

Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status.

D. Rizopoulos, R. Stupp, T. Gorlia, 2023, European journal of cancer.

OS07.8.A Prognosis in IDH-mutant glioma: the role of extent-of-resection, age and tumor grade

M. J. van den Bent, P. French, J. Kros, 2022, Neuro-Oncology.

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

M. J. van den Bent, T. Gorlia, B. Ylstra, 2024, bioRxiv.

Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide

P. Lohmann, K. V. van Garderen, N. Galldiks, 2024, Neuro-oncology.